173 related articles for article (PubMed ID: 20514493)
1. Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level.
Zheng HC; Wang W; Xu XY; Xia P; Yu M; Sugiyama T; Takano Y
J Cancer Res Clin Oncol; 2011 Apr; 137(4):585-96. PubMed ID: 20514493
[TBL] [Abstract][Full Text] [Related]
2. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
Zheng HC; Takahashi H; Murai Y; Cui ZG; Nomoto K; Miwa S; Tsuneyama K; Takano Y
Br J Cancer; 2006 Nov; 95(10):1371-8. PubMed ID: 17088917
[TBL] [Abstract][Full Text] [Related]
3. Aberrant SERCA3 expression during the colorectal adenoma-adenocarcinoma sequence.
Gou WF; Niu ZF; Zhao S; Takano Y; Zheng HC
Oncol Rep; 2014 Jan; 31(1):232-40. PubMed ID: 24213720
[TBL] [Abstract][Full Text] [Related]
4. The role of EMMPRIN expression in ovarian epithelial carcinomas.
Zhao Y; Chen S; Gou WF; Niu ZF; Zhao S; Xiao LJ; Takano Y; Zheng HC
Cell Cycle; 2013 Sep; 12(17):2899-913. PubMed ID: 23966157
[TBL] [Abstract][Full Text] [Related]
5. Bag-3 expression is involved in pathogenesis and progression of colorectal carcinomas.
Yang X; Tian Z; Gou WF; Takahashi H; Yu M; Xing YN; Takano Y; Zheng HC
Histol Histopathol; 2013 Sep; 28(9):1147-56. PubMed ID: 23553442
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis.
Takahashi H; Wang JP; Zheng HC; Masuda S; Takano Y
Histol Histopathol; 2011 Jun; 26(6):663-71. PubMed ID: 21472681
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological significance of REIC expression in colorectal carcinomas.
Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
[TBL] [Abstract][Full Text] [Related]
8. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
[TBL] [Abstract][Full Text] [Related]
9. Downregulated inhibitor of growth 3 (ING3) expression during colorectal carcinogenesis.
Gou WF; Sun HZ; Zhao S; Niu ZF; Mao XY; Takano Y; Zheng HC
Indian J Med Res; 2014 Apr; 139(4):561-7. PubMed ID: 24927342
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
[TBL] [Abstract][Full Text] [Related]
11. EMMPRIN expression is associated with metastatic progression in osteosarcoma.
Kim HS; Kim HJ; Lee MR; Han I
BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336
[TBL] [Abstract][Full Text] [Related]
12. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
[TBL] [Abstract][Full Text] [Related]
13. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
14. Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
Zheng HC; Xu XY; Xia P; Yu M; Takahashi H; Takano Y
Hum Pathol; 2010 Sep; 41(9):1255-64. PubMed ID: 20447678
[TBL] [Abstract][Full Text] [Related]
15. The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression.
Madigan MC; Kingsley EA; Cozzi PJ; Delprado WJ; Russell PJ; Li Y
Cancer Immunol Immunother; 2008 Sep; 57(9):1367-79. PubMed ID: 18273614
[TBL] [Abstract][Full Text] [Related]
16. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.
Sato M; Nakai Y; Nakata W; Yoshida T; Hatano K; Kawashima A; Fujita K; Uemura M; Takayama H; Nonomura N
PLoS One; 2013; 8(9):e74313. PubMed ID: 24073208
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Siddiquei MM; Mohammad G; Hertogh G; Mousa A; Opdenakker G
Acta Ophthalmol; 2017 Nov; 95(7):697-704. PubMed ID: 27860331
[TBL] [Abstract][Full Text] [Related]
18. Beclin 1 expression is closely linked to colorectal carcinogenesis and distant metastasis of colorectal carcinoma.
Zhang MY; Gou WF; Zhao S; Mao XY; Zheng ZH; Takano Y; Zheng HC
Int J Mol Sci; 2014 Aug; 15(8):14372-85. PubMed ID: 25196438
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasis.
Huang Z; Tan N; Guo W; Wang L; Li H; Zhang T; Liu X; Xu Q; Li J; Guo Z
PLoS One; 2014; 9(4):e91596. PubMed ID: 24705283
[TBL] [Abstract][Full Text] [Related]
20. ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
Xu Q; Ying M; Chen G; Lin A; Xie Y; Ohara N; Zhou D
Tumour Biol; 2014 Aug; 35(8):7575-86. PubMed ID: 24793016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]